Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TransMedics Group, Inc.
Report date February 01, 2023 · Filed February 03, 2023
Section 16 reporting ended · disclosed 2023-02-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,120 |
Ending reported balance
After 2023-02-01 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2023-02-01 · Exercise / conversion · Acquired 1,363 · Balance 15,483 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Row 2 · 2023-02-01 · Exercise / conversion · Acquired 47 · Balance 15,530 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Row 3 · 2023-02-01 · Sale · Disposed 582 · Balance 14,948 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 4 · 2023-02-01 · Sale · Disposed 379 · Balance 14,569 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 5 · 2023-02-01 · Sale · Disposed 96 · Balance 14,473 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 6 · 2023-02-01 · Sale · Disposed 139 · Balance 14,334 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 7 · 2023-02-01 · Sale · Disposed 214 · Balance 14,120 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.14 · Expires 2030-02-27 | Direct | 4,887 |
Reported balance
After 2023-02-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-02-01 · Exercise / conversion · Disposed 1,363 · Balance 4,887 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.46 · Expires 2031-02-24 | Direct | 13,543 |
Reported balance
After 2023-02-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-02-01 · Exercise / conversion · Disposed 47 · Balance 13,543 F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F8: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F7: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
F8: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2021 Filed Aug 4, 2021 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-031623 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,313 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,680 | $28.33 | $47,594.40 |
DisclosureSEC source: 0000899243-21-031623 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $28.54 to $29.14, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:00 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-031623 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,993 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 200 | $34.05 | $6,810.00 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.04 to $34.06, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,480 | $33.60 | $49,728.00 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $33.02 to $34.00, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 10:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-027478 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:09 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,680 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-021819 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,673 Underlying: Common Stock · 1,680 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:09 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,680 | $26.01 | $43,696.80 |
DisclosureSEC source: 0000899243-21-021819 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.05, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:09 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,680 | $2.21 | $3,712.80 |
DisclosureSEC source: 0000899243-21-021819 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 978 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-21-018420 · doc4.xml · derivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,353 Underlying: Common Stock · 978 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 702 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-21-018420 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Stock · 702 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 300 | $28.87 | $8,661.00 |
DisclosureSEC source: 0000899243-21-018420 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $28.80 to $28.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,380 | $28.22 | $38,943.60 |
DisclosureSEC source: 0000899243-21-018420 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $27.79 to $28.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 978 | $2.21 | $2,161.38 |
DisclosureSEC source: 0000899243-21-018420 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 03, 2021 Filed May 5, 2021 23:47 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 702 | $16.14 | $11,330.28 |
DisclosureSEC source: 0000899243-21-018420 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,360 | $0.00 Strike: $16.14 | $0.00 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · derivative · entry 7 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,640 Underlying: Common Stock · 3,360 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F7 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 200 | $40.48 | $8,096.00 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · nonDerivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.28 to $40.67, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 600 | $38.68 | $23,208.00 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · nonDerivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $38.09 to $39.08, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,000 | $37.62 | $37,620.00 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $37.01 to $38.00, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 800 | $35.99 | $28,792.00 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $35.50 to $36.48, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 760 | $34.43 | $26,166.80 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $34.17 to $34.78, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:34 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 3,360 | $16.14 | $54,230.40 |
DisclosureSEC source: 0000899243-21-015323 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 02:19 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 3,200 | $37.50 | $120,000.00 |
DisclosureSEC source: 0000899243-21-011242 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:51 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000899243-21-008456 · doc4.xml · derivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-02-24 F1 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 22:41 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-024190 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 22:41 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,000 | $17.59 | $35,180.00 |
DisclosureSEC source: 0000899243-20-024190 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.23 to $17.90 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 22:41 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,000 | $0.39 | $780.00 |
DisclosureSEC source: 0000899243-20-024190 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,331 Underlying: Common Stock · 2,000 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 142 | $18.96 | $2,692.32 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $18.90 to $19.02 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,858 | $18.58 | $34,521.64 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,342 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.90 to $18.88 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:08 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,000 | $2.21 | $4,420.00 |
DisclosureSEC source: 0000899243-20-021569 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,106 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · derivative · entry 6 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,331 Underlying: Common Stock · 1,106 shares Expires 2027-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests as a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, June 22, 2017. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 894 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · derivative · entry 5 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 894 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 600 | $17.92 | $10,752.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · nonDerivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.59 to $18.27 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,400 | $16.73 | $23,422.00 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.50 to $17.16 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,106 | $2.21 | $2,444.26 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:42 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 894 | $0.39 | $348.66 |
DisclosureSEC source: 0000899243-20-018365 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:10 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-014932 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,894 Underlying: Common Stock · 2,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:10 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,000 | $13.21 | $26,420.00 |
DisclosureSEC source: 0000899243-20-014932 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $13.04 to $13.44 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:10 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,000 | $0.39 | $780.00 |
DisclosureSEC source: 0000899243-20-014932 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 01, 2020 Filed May 4, 2020 22:04 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-011912 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,894 Underlying: Common Stock · 2,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 01, 2020 Filed May 4, 2020 22:04 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 500 | $17.63 | $8,815.00 |
DisclosureSEC source: 0000899243-20-011912 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.50 to $17.73, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 01, 2020 Filed May 4, 2020 22:04 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,500 | $16.86 | $25,290.00 |
DisclosureSEC source: 0000899243-20-011912 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.45 to $17.39 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 01, 2020 Filed May 4, 2020 22:04 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,000 | $0.39 | $780.00 |
DisclosureSEC source: 0000899243-20-011912 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 20:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-010608 · doc4.xml · derivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,894 Underlying: Common Stock · 2,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 20:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 2,000 | $13.10 | $26,200.00 |
DisclosureSEC source: 0000899243-20-010608 · doc4.xml · nonDerivative · entry 2 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $13.00 to $13.83, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 20:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 2,000 | $0.39 | $780.00 |
DisclosureSEC source: 0000899243-20-010608 · doc4.xml · nonDerivative · entry 1 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0000899243-20-006952 · doc4.xml · derivative · entry 4 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,894 Underlying: Common Stock · 2,000 shares Expires 2021-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 100 | $15.98 | $1,598.00 |
DisclosureSEC source: 0000899243-20-006952 · doc4.xml · nonDerivative · entry 3 Carey John F · CIK 0001774272 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.